menu search

Plus therapeutics receives $1.9 million advance payment from cprit and plans to present at the cprit innovations in cancer prevention and research conference

AUSTIN, Texas, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq:  PSTV ) (the “Company”), a clinical-stage ...

September 11, 2023, 7:00 am

Eagle pharmaceuticals to present cal02 trial in progress at the 2023 asm/escmid joint conference on drug development to meet the challenge of antimicrobial resistance

-- CAL02 is a unique therapeutic agent that is designed to work differently from antibiotics, aiming to disarm an infectious pathogen's virulence fact...

September 11, 2023, 6:50 am

Neumora therapeutics sets ipo terms, to be valued at up to $2.7 billion

Neumora Therapeutics Inc. NMRA, has set terms for its initial public offering, as the Massachusetts-based biop...

September 11, 2023, 6:46 am

Softbank-backed neumora therapeutics aims to raise up to $264.8 mln in us ipo

Biopharmaceutical firm Neumora Therapeutics, backed by Amgen and Japan's SoftBank , is aiming to raise ...

September 11, 2023, 6:15 am

Immuron ceo, steven lydeamore to present at h.c. wainwright

MELBOURNE, Australia, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated bio...

September 11, 2023, 6:00 am

Adding zymeworks to my value watchlist (initial buy rating)

Zymeworks is a biotech company focused on developing therapies for hard-to-treat cancers. Its lead product, zanidatamab, has shown promising results i...

September 11, 2023, 3:06 am

Allist and arrivent announce interim results from ongoing phase 1b trial with furmonertinib at the 2023 world conference on lung cancer

SHANGHAI, China, Sept. 10, 2023 (GLOBE NEWSWIRE) — Allist pharmaceuticals Co., Ltd. (“Allist”) an...

September 10, 2023, 5:30 am

Only 2 mega-cap monster stocks have risen in each of the last 5 years: are they buys now?

Of the more than 40 current mega-cap stocks, only two have generated positive returns in each of the last five years. One is a highly diversified cong...

September 9, 2023, 5:52 am

Rosen, national trial lawyers, encourages apellis pharmaceuticals, inc. investors to secure counsel before important deadline in securities class action – apls

NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis ...

September 8, 2023, 9:34 pm

Rosen, national trial lawyers, encourages apellis pharmaceuticals, inc. investors to secure counsel before important deadline in securities class action – apls

NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis ...

September 8, 2023, 9:28 pm

: regeneron cfo landry to retire, top accountant fenimore to become cfo

Regeneron pharmaceuticals Inc. REGN said late Friday that Chief Financial Officer Robert E. Landry will...

September 8, 2023, 9:03 pm

Regeneron provides update on planned chief financial officer transition

Robert E. Landry to retire effective February 2024; Christopher Fenimore, long-standing Senior Vice President, Head of Accounting and Controller, to a...

September 8, 2023, 8:46 pm

Regeneron cfo landry to retire, top accountant fenimore to become cfo

Regeneron pharmaceuticals Inc. REGN, +0.66% said late Friday that Chief Financial Officer Robert E. Lan...

September 8, 2023, 5:03 pm

What makes olema pharmaceuticals, inc. (olma) a new buy stock

Olema pharmaceuticals, Inc. (OLMA) might move higher on growing optimism about its earnings prospects, ...

September 8, 2023, 1:32 pm

Why is ionis pharmaceuticals (ions) up 1.4% since last earnings report?

Ionis pharmaceuticals (IONS) reported earnings 30 days ago. What's next for the stock?...

September 8, 2023, 12:47 pm

Recursion pharmaceuticals has a prescription for high drug costs: ai and 25 petabytes of data

Amid fierce debate about prescription-drug prices and countless proposals to rein them in, there has been a point of widespread agreement: Those price...

September 8, 2023, 12:38 pm

Syndax pharmaceuticals: positive axatilimab phase 2 results

Syndax is making strides in the adoption of entinostat, a cancer therapeutic used in combination with immune checkpoint therapies. Syndax reported an ...

September 8, 2023, 10:42 am

What makes olema pharmaceuticals, inc. (olma) a good fit for 'trend investing'

Olema pharmaceuticals, Inc. (OLMA) could be a great choice for investors looking to make a profit from ...

September 8, 2023, 10:32 am

1 top pharma growth stock to buy today and hold forever

Vertex pharmaceuticals has many avenues for chasing growth both big and small. Its cystic fibrosis medi...

September 8, 2023, 10:15 am

The 3 best pharma stocks to buy now: september 2023

The pharmaceutical sector will always be a sector in constant evolution and growth. As technology advan...

September 8, 2023, 9:14 am


Search within

Pages Search Results: